Professional Education

Elevating patient care

Educational resources to help improve your expertise in treating psoriasis.

On-line CME ProgramsCase-based learning activities

Congress CoveragePsoriasis highlights from major dermatology and psoriasis congresses

Top ManuscriptsExpert perspectives on current research

Psoriasis Review NewsletterPsoriasis highlights from major dermatology and psoriasis congresses

Video LecturesHot topics and challenges cases from congresses around the world

Live Events Satellite symposia at major congresses and 2-day Master Classes

Psoriasis News

Statement on the Coronavirus (COVID-19) Outbreak

3/11/2020 1:09:00 PM

For psoriasis patients diagnosed with COVID-19 disease, the IPC recommends physicians discontinue or postpone use of immunosuppressant medications. This is in accordance with established psoriasis treatment guidelines, which state immunosuppressive psoriasis treatments are contraindicated in patients with active infections.

NOW AVAILABLE: IPC's January 2020 Psoriasis Review newsletter

2/6/2020 10:54:00 AM

Just published - IPC's latest issue of the Psoriasis Review newsletter is now available! This issue features the Top Five Papers in psoriasis research, symposia reports, IPC news, and more!

IPC Think Tank 2019

2/6/2020

AbbVie Launches Let Me Be Clear to Empower People with Psoriasis to Speak Up and Seek Freedom from Their Disease

11/5/2019 9:16:00 AM

AbbVie, a research-based global biopharmaceutical company, today announced the launch of Let Me Be Clear, an empowerment platform for people living with psoriasis. The initiative, which launches on World Psoriasis Day, invites people living with psoriasis to share their story, discuss what freedom from psoriasis would mean to them and access tools to have clear and informed conversations with their physicians.

More News

Professional Education

Biomarkers in psoriasis and psoriatic arthritis: moving toward personalized therapy

Psoriasis News

Advancing Knowledge. Enhancing Care.